Source: Eur Respir J 2003; 22: 457-461
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Ichinose M., Sugiura H., Yamagata S., Koarai A., Tomaki M., Ogawa H., Komaki Y., Barnes P.J., Shirato K., Hattori T.. Xanthine oxidase inhibition reduces reactive nitrogen species production in COPD airways. Eur Respir J 2003; 22: 457-461

Member's Comments

No comment yet.

Related content which might interest you: Exhaled nitric oxide and hydrogen peroxide in patients with asthma and chronic obstructive pulmonary disease Source: Eur Respir J 2007; 30: Suppl. 51, 617s Year: 2007 Xanthine oxidase inhibition reduces reactive nitrogen species production in COPD airways Source: Eur Respir J 2004; 23: 496 Year: 2004 Increased alveolar nitric oxide concentration in asthmatic patients with nocturnal symptoms Source: Eur Respir J 2002; 20: 841-845 Year: 2002 Sputum neutrophilia is correlated with levels of exhaled nitric oxide (NO) in patients with chronic, stable sarcoidosis Source: Eur Respir J 2001; 18: Suppl. 33, 344s Year: 2001 Fractional exhaled nitric oxide in chronic obstructive pulmonary disease Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 Fractional exhaled nitric oxide in patients with chronic obstructive pulmonary disease Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification Year: 2019 Increased nitrotyrosine in exhaled breath condensate in cystic fibrosis Source: Eur Respir J 2001; 17: 1201-1207 Year: 2001 Differential assessment of airway inflammation in chronic obstructive pulmonary disease (COPD) by measurements of exhaled nitric oxide (NO) derived from peripheral vs. central airways Source: Eur Respir J 2003; 22: Suppl. 45, 279s Year: 2003 Exhaled nitric oxide in respiratory diseases other than asthma Source: Eur Respir Monogr 2010; 49: 45-55 Year: 2010 Hyperinflation is associated with reduced nitric oxide production in COPD Source: Eur Respir J 2005; 26: Suppl. 49, 226s Year: 2005 Bronchial and alveolar exhaled nitric oxide as a marker of systemic involvement in patients with Crohn‘s disease Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011 Reactive oxygen species generation and exhaled nitric oxide in atopic mild bronchial asthma in exacerbation Source: Eur Respir J 2002; 20: Suppl. 38, 49s Year: 2002 Severity of scleroderma lung disease is related to alveolar concentration of nitric oxide Source: Eur Respir J 2007; 30: 26-30 Year: 2007 Use of different exhaled nitric oxide multiple flow rate models in COPD Source: Eur Respir J 2007; 29: 651-659 Year: 2007 Increased eNO and pulmonary iNOS expression in eNOS null mice Source: Eur Respir J 2003; 21: 770-773 Year: 2003 Exhaled nitric oxide in chronic obstructive pulmonary disease: relationship to pulmonary function Source: Eur Respir J 2001; 17: 934-938 Year: 2001 Superiority of hydrogen peroxide to exhaled nitric oxide as a marker of bronchial inflammation in asthmatic children Source: Annual Congress 2008 - Paediatric airway diseases - pathophysiology and monitoring Year: 2008 The use of exhaled nitric oxide concentration as a means of excluding eosinophilic inflammation in chronic cough Source: Annual Congress 2009 - From cough to sound analysis of breathing Year: 2009 Bronchial nitric oxide is related to symptom relief during fluticasone treatment in COPD Source: Eur Respir J 2010; 35: 72-78 Year: 2010 Utility of exhaled nitric oxide as a noninvasive biomarker of lung inflammation in a disease model Source: Eur Respir J 2006; 28: 1236-1244 Year: 2006